COLO News - Candlesense

Coloplast A/S - Interim Financial Report, 9M 2024/25

2024/25

What guidance or outlook does the company provide for the remainder of the fiscal year, and how might this affect the stock's valuation and momentum? How does Coloplast's interim financial results compare to market expectations and its peers in the medical device sector? What are the key drivers behind the reported revenue and earnings performance for the first 9 months of 2024/25?

Earnings

15 days ago

Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team

Coloplast announces changes to Executive Leadership Team

How are investors likely to react to this management transition in terms of stock price volatility and trading volume? What potential operational or strategic shifts might result from the new executive appointments, and how could they influence the company's market position? How will the leadership changes affect Coloplast's upcoming earnings guidance and revenue growth?

Management

15 days ago

Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST

Tuesday, 19 August 2025 at 11.00 - 12.00h CEST In connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST,...

Are there any upcoming catalysts or events (e.g., regulatory approvals, M&A activity, conferences) that could influence the stock price in the near term? What is the expected impact of the 9M results on the stock’s technical indicators (e.g., support/resistance levels) in the short‑term? How does the current valuation (P/E, EV/EBITDA) compare to key competitors in the medical device sector after this release?

Earnings

26 days ago